Amyloid in the islets of Langerhans: Thoughts and some historical aspects

Upsala Journal of Medical Sciences

Volumn 116, Issue 2, 2011, Pages 81-89

  Westermark, Per ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amyloid; b cell mass; b cells; IAPP; islets of Langerhans; protein aggregation; type 2 diabetes

Indexed keywords

AMYLIN;

ANIMAL; AWARDS AND PRIZES; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY; REVIEW;

ANIMALS; AWARDS AND PRIZES; DIABETES MELLITUS, TYPE 2; HUMANS; ISLET AMYLOID POLYPEPTIDE; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION;

EID: 79954510553     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009734.2011.573884     Document Type: Review

References (79)

1. Westermark P, Wernstedt C, Wilander E, Sletten K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun. 1986;140:827-31. (Pubitemid 17207764)
2. Opie EL. On relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes mellitus. J Exp Med. 1901;5:397-428.
3. Weichselbaum A, Stangl E. Zur Kenntnis der feineren Veränderungen des Pankreas bei Diabetes mellitus. Wien Klin Wochenshr. 1901;14:968-72.
4. Gellerstedt N. Die elektive, insuläre (Para-)Amyloidose der Bauchspeicheldrüse. Zugleich en Beitrag zur Kenntnis der senilen Amyloidose'. Beitr Path Anat. 1938;101:1-13.
5. Ehrlich JC, Ratner IM. Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and nondiabetic individuals. Am J Path. 1961;38:49-59.
6. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, et al. Amyloid fibril protein nomenclature: 2010 recommendations of the nomenclature committee of the International Society of Amyloidosis. Amyloid. 2010;17: 101-4.
7. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA. 1987;84:3881-5. (Pubitemid 17088383)
8. Ahronheim JH. The nature of the hyaline material in the pancreatic islands in diabetes mellitus. Am J Path. 1943;19: 873-82.
9. Bell ET. Hyalinization of the islets of Langerhans in nondiabetic individuals. Am J Path. 1959;35:801-5.
10. Westermark P. Quantitative studies of amyloid in the islets of Langerhans. Ups J Med Sci. 1972;77:91-4.
11. Pearse AGE, Ewen SWB, Polak JM. The genesis of apudamyloid in endocrine polypeptide tumours: Histochemical distinction from immunamyloid. Virchows Arch Abt B Zellpath. 1972;10:93-107.
12. Westermark P. Amyloid of human islets of Langerhans. I. Isolation and some characteristics. Acta Path Microbiol Scand C. 1975;83:439-46.
13. Glenner GG, TerryW, HaradaM, Isersky C, Page D. Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analysis. Science. 1971;172:1150-1.
14. Benditt EP, Eriksen N, Hermodson MA, Ericsson LH. The major proteins of human and monkey amyloid substance: common properties including unusual N-terminal amino acid sequences. FEBS Lett. 1971;19:169-73.
15. Sletten K, Westermark P, Natvig JB. Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med. 1976;143:993-8.
16. Masters C, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core proteinin Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA. 1985;82:4245-9. (Pubitemid 15053619)
17. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Path. 1987;127:414-17. (Pubitemid 17089802)
18. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA. 1987;84:8628-32. (Pubitemid 18033465)
19. Cooper GJS, Day AJ, Willis AC, Roberts AN, Reid KBM, Leighton B. Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitus. Biochim Biophys Acta. 1989;1014:247-58. (Pubitemid 20009797)
20. Westermark P, Wilander E, Westermark GT, Johnson KH. Islet amyloid polypeptide-like immunoreactivity in the islet B cells of Type 2 (non-insulin-dependent) diabetic and nondiabetic individuals. Diabetologia. 1987;30:887-92. (Pubitemid 18003672)
21. Johnson KH, O'Brien TD, Hayden DW, Jordan K, Ghobrial HKG, Mahoney WC, et al. Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. Am J Path. 1988;130:1-8. (Pubitemid 18044828)
22. Lukinius A, Wilander E, Westermark GT, Engström U, Westermark P. Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia. 1989;32:240-4. (Pubitemid 19136367)
23. Westermark GT, Christmanson L, Terenghi G, Permert J, Betsholtz C, Larsson J, et al. Islet amyloid polypeptide: demonstration of mRNA in human pancreatic islets by in situ hybridization in islets with and without amyloid deposits. Diabetologia. 1993;36:323-8. (Pubitemid 23106016)
24. Westermark P. Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch A. 1973;359:1-18.
25. Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid and diabetes mellitus. Physiol Rev. 2011. In press.
26. Betsholtz C, Christmanson L, Engström U, Rorsman F, Svensson V, Johnson KH, et al. Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett. 1989;251:261-4. (Pubitemid 19181881)
27. Nishi M, Chan SJ, Nagamatsu S, Bell GI, Steiner DF. Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone. Proc Natl Acad Sci USA. 1989;86: 5738-42. (Pubitemid 19217530)
28. Fan L, Westermark G, Chan SJ, Steiner DF. Altered gene structure and tissue expression on islet amyloid polypeptide in the chicken. Mol Endocrinol. 1994;8:713-21. (Pubitemid 24179663)
29. Westermark GT, Falkmer S, Steiner DF, Chan SJ, Engström U, Westermark P. Islet amyloid polypeptide is expressed in the pancreatic islet parenchyma of the teleostean fish, Myoxocephalus (Cottus) scorpius. Comp Biochem Physiol B. 2002;133:119-25. (Pubitemid 35266658)
30. Martínez-Álvarez RM, Volkoff H, Munoz Cueto JA, Delgado MJ. Molecular characterization of calcitonin generelated peptide (CGRP) related peptides (CGRP, amylin, adrenomedullin and adrenomedullin-2/intermedin) in goldfish (Carassius auratus): Cloning and distribution. Peptides. 2008;29:1534-43.
31. Howard CFJ. Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia. 1986;29: 301-6.
32. de Koning EJP, Bodkin NL, Hansen BC, Clark A. Diabetes mellitus in Macaca mulatta monkeys is characterized by islet amyloidosis and reduction in beta-cell population. Diabetologia. 1993;36:378-84. (Pubitemid 23124039)
33. Johnson KH, Stevens JB. Light and electron microscopic studies of islet amyloid in diabetic cats. Diabetes. 1973;22: 81-90.
34. Johnson KH, Hayden DW, O'Brien TD, Westermark P. Spontaneous diabetes-islet amyloid complex in adult cats. Am J Path. 1986;125:416-19.
35. Johnson KH, Wernstedt C, O'Brien TD, Westermark P. Amyloid in the pancreatic islets of the cougar (Felis concolor) is derived from islet amyloid polypeptide (IAPP). Comp Biochem Physiol. 1991;98B:115-19.
36. Betsholtz C, Christmanson L, Engström U, Rorsman F, Jordan K, O'Brien TD, et al. Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes. 1990;39:118-22. (Pubitemid 20022894)
37. Westermark P, Engström U, Johnson KH, Westermark GT, Betsholtz C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA. 1990;87:5036-40.
38. Opazo JC, Soto-Gamboa M, Bozinovic F. Blood glucose concentration in caviomorph rodents. Comp Biochem Physiol A Mol Integr Physiol. 2004;137:57-64. (Pubitemid 38076999)
39. Nishi M, Steiner DF. Cloning of complementary DNAs encoding islet amyloid polypeptide, insulin, and glucagon precursors from a new world rodent, the degu, Octodon degus. Mol Endocrinol. 1990;4:1192-8.
40. Hellman U, Wernstedt C, Westermark P, O'Brien TD, Rathbun WB, Johnson KH. Amino acid sequence from degu islet amyloid-derived insulin shows unique sequence characteristics. Biochem Biophys Res Commun. 1990;169: 571-7. (Pubitemid 20216146)
41. Westermark P. On the nature of the amyloid in human islets of Langerhans. Histochemistry. 1974;38:27-33.
42. Dische FE, Wernstedt C, Westermark GT, Westermark P, Pepys MB, Rennie JA, et al. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia. 1988;31:158-61.
43. Yumlu S, Barany R, Eriksson M, Röcken C. Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report. Hum Path. 2009;40:1655-60.
44. Howie AJ, Owen-Casey MP. Discrepancies between descriptions and illustrations of colours in Congo red-stained amyloid, and explanation of discrepant colours. Amyloid. 2010; 17:109-17.
45. Westermark P, Eizirik DL, Pipeleers DG, Hellerström C, Andersson A. Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia. 1995;38:543-9.
46. Paulsson JF, Andersson A, Westermark P, Westermark GT. Intracellular amyloid-like deposits contain unprocessed pro islet amyloid polypeptide (proIAPP) in beta-cells of transgenic mice overexpressing human IAPP and transplanted human islets. Diabetologia. 2006;49:1237-46.
47. Westermark P. Amyloid and polypeptide hormones: what is their inter-relationship? Amyloid. 1994;1:47-60.
48. Jarrett JT, Lansbury PT. Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 1993;73:1055-8. (Pubitemid 23180480)
49. Goldschmidt L, Teng PK, Riek R, Eisenberg D. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Natl Acad Sci USA. 2010;107:3487-92.
50. Westermark P, Engström U, Westermark GT, Johnson KH, Permerth J, Betsholtz C. Islet amyloid polypeptide (IAPP) and pro-IAPP immunoreactivity in human islets of Langerhans. Diab Res Clin Pract. 1989;7:219-26. (Pubitemid 19231484)
51. Westermark GT, Steiner DF, Gebre-Medhin S, Engström U, Westermark P. Pro islet amyloid polypeptide (proIAPP) immunoreactivity in amyloid formation in the islets of Langerhans. Ups J Med Sci. 2000;105:97-106.
52. Paulsson JF, Westermark GT. Aberrant processing of human proislet amyloid polypeptide results in increased amyloid production. Diabetes. 2005;54:2117-25. (Pubitemid 40911275)
53. Mulder H, Ahrén B, Sundler F. Islet amyloid polypeptide and insulin gene expression are regulated in parallel by glucose in vivo in rats. Am J Physiol. 1996;271:E1008-14.
54. Westermark P, Li Z-C, Westermark GT, Leckström A, Steiner DF. Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett. 1996; 379:203-6. (Pubitemid 26049441)
55. Janciauskiene S, Eriksson S, Carlemalm E, Ahrén B. b cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. Biochem Biophys Res Commun. 1997;236:580-5. (Pubitemid 27384668)
56. Jaikaran ETAS, Nilsson MR, Clark A. Pancreatic b-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation. Biochem J. 2004; 377:709-16. (Pubitemid 38221842)
57. Kisilevsky R, Ancsin JB, Szarek WA, Petanceska S. Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications. Amyloid. 2007;14:21-32. (Pubitemid 46491162)
58. Westermark P, Skinner M, Cohen AS. The P-component of amyloid of human islets of Langerhans. Scand J Immunol. 1975;4:95-7.
59. Coker AR, Purvis A, Baker D, Pepys MB, Wood SP. Molecular chaperone properties of serum amyloid P component. FEBS Lett. 2000;473:199-202. (Pubitemid 30254290)
60. Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes. 1999;48:491-8. (Pubitemid 29106861)
61. Dobson CM. Principles of protein folding, misfolding and aggregation. Semin Cell Develop Biol. 2004;15:3-16. (Pubitemid 38177363)
62. Hellman B. Pulsatility of insulin release - a clinically important phenomenon. Ups J Med Sci. 2009;114:193-205.
63. Juhl CB, Pørksen N, Sturis J, Hansen AP, Veldhuis JD, Pincus S, et al. High-frequency oscillations in circulating amylin concentrations in healthy humans. Am J Physiol Endocrinol Metab. 2000;278:E484-90. (Pubitemid 30149393)
64. Jurgens CA, Toukatly MN, Fligner CL, Udayasankar J, Subramanian SL, Zraika S, et al. Beta-cell loss and beta-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am J Path. 2011. In press.
65. Guardado-Mendoza R, Davalli AM, Chavez AO, Hubbard GB, Dick EJ, Majluf-Cruz A, et al. Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons. Proc Natl Acad Sci U S A. 2009;106:13992-7.
66. Maclean N, Ogilvie RF. Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes. 1955;4:367-76.
67. Gepts W. Die histopatohlogischen Veränderungen der Langerhansschen Inseln und ihre Bedeutung in der Frage der Pathogenese des menschlichen Diabetes. Endokrinologie. 1958;36:185-211.
68. Klöppel G, Drenck CR. Immunzytochemische Morphometrie beim Typ-1- und Typ-2-Diabetes mellitus. Deutsch Med Wschr. 1983;108:188-9. (Pubitemid 13184817)
69. Westermark P,Wilander E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia. 1978;15:417-21. (Pubitemid 9046993)
70. Westermark P, Grimelius L. The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Path Microbiol Scand A. 1973;81:291-300.
71. Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, et al. Islet amyloid, increased A-cells, reduced β-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diab Res. 1988;9:151-9. (Pubitemid 19105415)
72. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab. 2008;10 Suppl 4:32-42.
73. Hoenig M. The cat as a model for human nutrition and disease. Curr Opin Clin Nutr Metab Care. 2006;9:584-8. (Pubitemid 44258033)
74. Carlsson P-O. Influence of microenvironment on engraftment of transplanted β-cells. Ups J Med Sci. 2011;116:1-7.
75. Andersson A, Borg H, Groth CG, Gunnarsson R, Hellerström C, Lundgren G, et al. Survival of isolated human islets of Langerhans maintained in tissue culture. J Clin Invest. 1976;57:1295-301.
76. Westermark GT, Westermark P, Nordin A, Törnelius E, Andersson A. Formation of amyloid in human pancreatic islets transplanted to the liver and spleen of nude mice. Ups J Med Sci. 2003;108:193-204.
77. Westermark P, Andersson A, Westermark GT. Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets? Curr Diab Rep. 2005;5:184-8. (Pubitemid 41599943)
78. Westermark GT, Westermark P, Berne C, Korsgren O. Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med. 008;359:977-9.
79. Porte D Jr. Banting lecture 1990. β-cells in type II diabetes mellitus. Diabetes. 1991;40:166-80.